코퍼스 내 인용 상위 5
전체 논문 (36편 · 1/2)
-
Trastuzumab Rezetecan: First Approval.
-
Dordaviprone: First Approval.
-
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies.
-
Imlunestrant: First Approval.
-
Taletrectinib: First Approval.
-
Treatment Sequencing in Advanced Urothelial Cancer.
-
Zeprumetostat: First Approval.
-
Zongertinib: First Approval.
-
First Line and Treatment Sequencing in EGFR-Mutated Metastatic NSCLC: What is Right for Which Patient?
-
Ziftomenib: First Approval.
-
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale.
-
Treating Pancreatic Ductal Adenocarcinoma: The Targeted Revolution is Here.
-
Becotatug Vedotin: First Approval.
-
Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Cirrhosis Clinical Trials: Lessons Learned and Future Directions.
-
Retlirafusp Alfa: First Approval.
-
Sevabertinib: First Approval.
-
Ifupinostat: First Approval.
-
Lisaftoclax: First Approval.
-
Liposomal Irinotecan: A Review as First-Line Therapy in Metastatic Pancreatic Adenocarcinoma.
-
Zenocutuzumab: First Approval.
-
Systemic Therapy for Advanced Thyroid Cancer-New Personalized Options.
-
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential.
-
Efficiency and Safety of Noninvasive and Intravesical Therapy for Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.
-
Zolbetuximab: First Approval.
-
RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future.
-
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews.
-
Pharmacological Management of Orofacial Pain.
-
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
-
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
-
Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches.